Literature DB >> 32213578

The Clinical Impact of a Negative Molecular β-Lactamase Gene Test for Enterobacteriaceae: Let's Not Let Perfect Be the Enemy of Really Good.

Jason M Pogue1, Emily L Heil2.   

Abstract

Keywords:  Enterobacteriaceaezzm321990; Verigene; ceftriaxone; extended-spectrum β-lactamase; molecular test

Mesh：

Substances：

Year:  2020        PMID： 32213578      PMCID： PMC7098734          DOI： 10.1128/JCM.02098-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  1 in total

1.  Evaluation of Empiric β-Lactam Susceptibility Prediction among Enterobacteriaceae by Molecular β-Lactamase Gene Testing.

Authors:  Kyle Spafford; Shawn MacVane; Romney Humphries
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948
  1 in total
  2 in total

Review 1.  Proceedings of the Clinical Microbiology Open 2018 and 2019 - a Discussion about Emerging Trends, Challenges, and the Future of Clinical Microbiology.

Authors:  Christopher D Doern; Melissa B Miller; Kevin Alby; Michael A Bachman; Stephen M Brecher; Aida Casiano-Colon; Marc Roger Couturier; J Kristie Johnson; James E Kirby; Erin McElvania; Duane W Newton; Frederick S Nolte; Preeti Pancholi; Peggy McNult; Vaishali Dharmarha; Sherry Dunbar
Journal:  J Clin Microbiol       Date:  2022-05-31       Impact factor: 11.677

2.  Using Molecular Diagnostics to Develop Therapeutic Strategies for Carbapenem-Resistant Gram-Negative Infections.

Authors:  Fred C Tenover
Journal:  Front Cell Infect Microbiol       Date:  2021-09-28       Impact factor: 5.293
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.